Venture
Anthemis venture fund to hold final close before H2 2021
To date, AIVGF I has secured backing from a number of investors such as NУМrnberger
Dawn closes fourth fund on $400m hard-cap
Dawn Capital III closed on ТЃ165m in April 2018 and has now made its final initial investment
Claris Biotech I holds €30m first closing
Fund targets early-stage rounds across the biopharmaceutical industry, focusing on oncology, immunology and rare diseases
Panakes to launch €120m second fund within months
VC expects to start raising capital by the end of the year and hold a first close in H1 2021
Euregio Plus to launch €50m VC fund
Fund intends to support the growth and expansion of startups and SMEs
Longevitytech.fund to resume fundraising in early September
Fund aims to hold a second close on $2-3m by February 2021 and to raise the remainder within a year
La Famiglia announces second fund
B2B-focused venture capital fund has made eight investments so far and is targeting €50m
DvH Ventures launches Digital Health Fund
Dieter von Holtzbrinck Ventures (DvH Ventures) has announced the launch of its first Digital Health fund, which has held a first close on €60m.
Axon launches €150m fourth innovation growth fund
Fondo Axon Innovation Growth IV acquires minority stakes in technology businesses with high-growth potential
UCL Technology Fund 2 holds first close on £100m
UCL Technology Fund closed on ТЃ50m in January 2016 and is now fully deployed
Programma 102 closes on €100m
VC will launch a new vehicle by the end of the year, with a тЌ100m target, to focus on complementary asset classes
Eureka Venture holds €38m first close for debut fund
Eureka Fund I invests in seed and series-A rounds, targeting deeptech companies
Primo Space Fund holds €58m first close
Vehicle has an €80m target and expects to hold a final close by the end of 2021
Nuveen Global Impact Fund holds $150m first close
Fund invests in growth-stage companies in developed and emerging markets, with a focus on resource efficiency
Blackstone Life Sciences V closes on $4.6bn
Fund invests in late-stage rounds of established life science companies and emerging businesses
ETF closes Environmental Technologies Fund III on £167m
Around 40 existing and new LPs, including British Patient Capital and the EIF, participated
Nauta Tech Invest V holds €120m first close
Fund deploys tickets of тЌ1-5m in seed and series-A rounds to support European B2B SaaS startups
Forbion holds first close for Growth Opportunities Fund
New strategy focuses on pre-IPO capital and capital for undervalued listed life sciences companies
B Capital closes second fund on $820m
Fund invests in series-B, -C and -D rounds to support B2B and B2C startups based across Asia, Europe and the US
Spanish impact fund Fondo Bolsa Social targets €25m
Fund targets early-stage companies able to generate a positive and measurable social or environmental impact
Aldea Ventures launches €150m fund-of-funds
VC house expects to hold a €35-45m first close by the end of July and a final close in around one year
Innvotec launches Female Ventures Fund
Fund provides initial capital, followed by further financial and advisory support after the early stages
EQT leads $3m seed round for Willa
Company will use the proceeds to launch its product Willa Pay
Summit Europe Growth Equity III closes on €1.1bn
Summit Europe III is structured as a Luxembourg LP, while Summit Partners itself is based in the US